Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Novo Nordisk (NVO.US) fell 3.3% to $38.48

Novo Nordisk (NVO.US) fell 3.3% to $38.48

老虎证券老虎证券2026/03/10 15:52
Show original
In terms of news, Novo Nordisk has received a warning letter from the U.S. Food and Drug Administration (FDA) for failing to report all suspected side effects experienced by patients taking the weight-loss drug Ozempic. The FDA pointed out in the letter that the cases included two deaths and one suicide, all involving patients who had received semaglutide treatment, which is the generic name for Ozempic and Wegovy. The FDA did not specify whether these deaths or other side effects were related to the drug. (Gelonghui)
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"The Big Short" Burry: AI infrastructure has become a key pillar of the US economy; Trump cannot afford to let the AI boom fail

Michael Burry stated that the current success of the artificial intelligence (AI) industry is just as crucial for the U.S. government as it is for the tech giants driving this boom.

智通财经•2026/09/28 07:16